Alembic Pharma said it is currently in litigation with Boehringer Ingelheim in District Court of Delaware and launch of the product will depend on litigation outcome.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Bdzq31
via IFTTT
Alembic Pharma gets tentative nod from USFDA for type-2 diabetes management drug
Alembic Pharma said it is currently in litigation with Boehringer Ingelheim in District Court of Delaware and launch of the product will depend on litigation outcome.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Bdzq31
via IFTTT
0 comments:
Post a Comment